# Low-cost Screening and Image-guided Photodynamic Therapy (PDT) of Premalignant and Malignant Oral Lesions

> **NCT06876038** · PHASE2 · NOT_YET_RECRUITING · sponsor: **University of Massachusetts, Boston** · enrollment: 65 (estimated)

## Conditions studied

- Oral Cancer
- Oral Cavity Cancer
- Oral Leukoplakia
- Oral Lichen Planus
- Oral Squamous Cell Carcinoma

## Interventions

- **DRUG:** 5-Amino Levulinic Acid

## Key facts

- **NCT ID:** NCT06876038
- **Lead sponsor:** University of Massachusetts, Boston
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09
- **Primary completion:** 2028-05
- **Final completion:** 2028-12
- **Target enrollment:** 65 (ESTIMATED)
- **Last updated:** 2026-03-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06876038

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06876038, "Low-cost Screening and Image-guided Photodynamic Therapy (PDT) of Premalignant and Malignant Oral Lesions". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT06876038. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*